4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0001482981-25-000143
CFO & Head of Corp. Dev. sold 52,000 shares at an average $21.62 ($1,124,335)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ridloff Elena CFO & Head of Corp. Dev. | 2025-08-19 | Sale 10b5-1 | −34,500 | $21.08 | $727,260 | 89,032 | D: show line 1 in the form |
| Ridloff Elena CFO & Head of Corp. Dev. | 2025-08-20 | Sale 10b5-1 | −17,500 | $22.69 | $397,075 | 71,532 | D: show line 2 in the form |
| Open-market sales · 52,000 sh · avg $21.62 · $1,124,335 | |||||||
Loading xslF345X05/edgardoc.xml…